Olive Oil With Omega 3 to Treat Stasis Dermatitis
Sponsor
Assaf-Harofeh Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00421161
Collaborator
(none)
30
3
1.9
10
5.2
Study Details
Study Description
Brief Summary
Olive oil and Omega 3 have many anti inflammatory effects that may be beneficial in the inflammation and edema of chronic stasis dermatitis. The olive oil contains many mono unsaturated fatty acids and anti oxidants that may add to the well being of a diseased skin by improving cell membrane homeostasis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1/Phase 2 |
Detailed Description
Patients with chronic stasis dermatitis due to venous insufficiency will be treated with the study cream and as control we will use "Venoroutone" . Patients will be followed weekly at the clinic of the vascular surgery at Assaf Harofeh MC.
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Phase 1 and 2 Study on the Efficacy and Side Effects of Olive Oil and Omega 3 Local Treatment in Stasis Dermatitis
Study Start Date
:
Jan 1, 2007
Study Completion Date
:
Mar 1, 2007
Outcome Measures
Primary Outcome Measures
- improvement in subjective and objective skin changes of patient: pain, edema, redness, size of involement, []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patints with stasis dermatitis for 6 months at least
Exclusion Criteria:
- skin ulceration or infection
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Assaf Harofe MC | Zerifin | Beer Yaacov | Israel | 70300 |
2 | Clinic of vascular surgery, Assaf Harofe MC | Zerifin | Israel | 70300 | |
3 | Clinic of Vascular Surgery | Zerifin | Israel | 70300 |
Sponsors and Collaborators
- Assaf-Harofeh Medical Center
Investigators
- Principal Investigator: Arie Bass, MD, Assaf Harofe MC
Study Documents (Full-Text)
None provided.More Information
Publications
Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00421161
Other Study ID Numbers:
- Refael Segal
First Posted:
Jan 11, 2007
Last Update Posted:
Jan 11, 2007
Last Verified:
Jan 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: